Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radojka Savic

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|August 15, 2009
Performance in population models for count data, part II: a new SAEM algorithmRadojka Savic, Marc Lavielle
Transactions of the American Clinical and Climatological Association|August 7, 2025
REVOLUTIONIZING TUBERCULOSIS REGIMEN DEVELOPMENTKelly E Dooley, Radojka Savic
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2022
Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS TrialMandar S Paradkar, Bella Devaleenal D, Tisungane Mvalo, et al.
Emerging Infectious Diseases|March 2, 2025
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with DiabetesEkaterina V Kurbatova, William C Whitworth, Lakshmi Praveena Peddareddy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2015
Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert PanelAmita Gupta, Jyoti S Mathad, Susan M Abdel-Rahman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Pharmacokinetics and Pharmacodynamics|August 15, 2009
Performance in population models for count data, part II: a new SAEM algorithmRadojka Savic, Marc Lavielle
Transactions of the American Clinical and Climatological Association|August 7, 2025
REVOLUTIONIZING TUBERCULOSIS REGIMEN DEVELOPMENTKelly E Dooley, Radojka Savic
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2022
Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS TrialMandar S Paradkar, Bella Devaleenal D, Tisungane Mvalo, et al.
Emerging Infectious Diseases|March 2, 2025
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with DiabetesEkaterina V Kurbatova, William C Whitworth, Lakshmi Praveena Peddareddy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2015
Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert PanelAmita Gupta, Jyoti S Mathad, Susan M Abdel-Rahman, et al.
Pageof 1